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Summary 
Recently several cell lines have been identified with mutations in a major histocompatibility complex 
(MHC)-linked protein that lead to defects in class II-restricted antigen presentation and a defect 
in the formation of class II SDS-stable dimers. The defect in these calls has recently been shown 
to result from the inability to express the MHC-encoded nonclassical  class II molecule called 
DM. To further examine the role of DM in class II-restricted antigen presentation, we asked 
if this defect would equally affect different allelic and species variants of class II molecules. To 
investigate this, we transfected the parent call lines T1  and 8.1.6  and their respective antigen 
presentation mutants T2 and 9.5.3  with the genes encoding I-A  d and examined the derived 
transfectants for their ability to present antigen, the conformation of I-A  a at the cell surface, 
association of I-A  a with invariant chain (Ii), and the ability to form I-A  d SDS-stable  dimers. 
The lack of functional DM expression did not affect any of the anti-I-A  d monoclonal antibody 
(mAb) epitopes tested or the ability of I-A  d to associate  and dissociate with Ii.  Surprisingly, 
these studies also revealed that the antigen presentation defect observed for DR. in the 9.5.3 
cells did not compromise I-Ad-restricted antigen presentation. In addition, we found that the 
level of SDS-stable dimer formation did not correlate with antigen presentation capacity for I-A  d 
and that the amount of SDS-stable  I-A  d dimer depends on the cellular context in which the 
class II molecule is expressed. Our results suggest that the ability to form SDS-stable  dimer 
is not strictly correlated with dass II-restricted antigen presentation. Finally,  when two allelic 
forms of murine class II molecules were compared in the defective T2 cell line,  it was found 
that I-A  k but not I-A  d forms SDS-stable dimers equivalent to that seen in the parental cell lines. 
Overall, our results suggest that DM may modulate rather than play a requisite role in I-A  d- 
restricted antigen presentation and SDS-stable  dimer formation and that dependency on DM 
may be allele or species  specific. 
M  HC class II molecules have the ability to present a wide 
. array of antigens derived from both exogenous and 
endogenous sources. Studies involving the use of lysosomo- 
tropic reagents (1), those that have examined the sites of class 
II localization within the APC (2-6),  the biochemistry of 
invariant chain (Ii) 1 (reviewed in 7), and class II conforma- 
tion (8-12) have led to a general model of class II-restricted 
antigen,presentation. In this model, class II molecules bind 
Ii in the endoplasmic reticulum (ER), an event which blocks 
the loading of most endogenous peptides (13, 14). The class 
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II/Ii complex then traffics out of the ER through the Golgi 
and trans-Gol~ network where it is sorted into the endo- 
cytic pathway. Within endocytic compartments, Ii is degraded 
and removed from the class II binding groove. Antigenic pep- 
tides produced from the proteolytic breakdown of internal- 
ized or endogenous antigens then bind class II molecules, 
an event that confers the SDS-stable phenotype. Finally,  the 
class II/peptide complex is exported to the cell surface for 
recognition by T  cells. 
Despite knowledge of many of the elements that regulate 
the function of class II molecules, there remains considerable 
uncertainty on the exact sequence of events that lead to ex- 
pression of functional peptide/class II complexes at the cell 
surface. Dissection of the intracellular mechanisms of antigen 
presentation has been greatly facilitated by the derivation of 
mutants. Several of these mutants have profound defects in 
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two of these mutant cell lines have now mapped the defect 
to the MHC-encoded nonclassical dass II-like proteins termed 
DMA and DMB (21-23).  Failure to express functional DM 
leads to a loss of two DR epitopes recognized by the anti- 
bodies 16.23 and 7.3.19 (17, 24),  several epitopes expressed 
on DQ and DP (23),  an inability to form SDS-stable  class 
II dimers, the loss of intact antigen presentation to several 
T cell clones and the failure to stimulate several allospecific 
T  cell clones.  These results suggest that DM expression  is 
required for antigen presentation by DR and that DM func- 
tions late in the class II pathway. 
To further examine the requirement for DM in antigen 
presentation and SDS-stable dimer formation, we transfected 
both the 8.1.6 and T1 cell lines, and their respective mutants 
9.5.3 and T2 that lack functional DM expression,  with the 
genes encoding the murine MHC class II molecule I-A  d. 
This allowed the study of DM's impact on the presentation 
of a wider panel of antigens than has been possible with hu- 
man class II molecules and also allowed us to examine the 
dass II I-Ad-restricted presentation of an endogenous antigen 
(H-2L  d) which is presented by a pathway distinct from the 
classical class I or class II pathways (25). Finally, this system 
permitted us to test the hypothesis that species- or allele- 
dependent differences in class II structure might modify the 
requirement for DM in the various activities of class II mol- 
ecules. 
Surprisingly, we have found that the lack of functional DM 
expression  has no detectable effect on class II-restricted an- 
tigen presentation to our panel of I-Aa-restricted T cells. In 
addition, through the analysis of several different cell types 
in which the murine class II molecule is expressed,  we have 
found little correlation between the generation of SDS-stable 
dimer and the efficiency of antigen presentation. Together 
our results suggest that allelic polymorphism and/or species 
variation in class II may modulate the requirement for DM 
in class II-restricted antigen presentation, and that the levels 
of SDS-stable dimer achieved within a given cell do not neces- 
sarily predict antigen presentation capacity. 
Materials  and Methods 
Cell Lines and Reagents.  Cell  lines were maintained  at 37~  and 
5% CO2 in either DMEM containing 5% FCS for the T cell hy- 
bridomas, KPMI 1640 containing 5% BCS for the 8.1.6 and 9.5.3 
ceU lines, and Iscove's containing 5% BCS for the 174XCEM.T1 
(T1) and 174XCEM.T2 (T2) cells, all supplemented with 5 mM 
HEPES, 2 mM glutamine, 1 mM nonessential amino acids, and 
5 x  10 -s M 2-ME. All medium and supplements were purchased 
from GIBCO BRL (Gaithersburg, MD) unless otherwise noted. 
8.1.6 and 9.5.3 were provided by Dr. E. Mellins (University of 
Pennsylvania, Philadelphia, PA) and T1 and T2 and the T1 and 
T2  I-A  k transfectants were provided by Dr.  P.  Cresswell (Yale 
University, New Haven, CT). T1/T2 and 8.1.6/9.5.3 were trans- 
fected with genes encoding I-A  d and H-2L  d using electroporation. 
Briefly, 5 x  106 cells were washed and resuspended in 0.8 ml PBS 
without Ca  2+ or Mg  ~+ containing 5 gg of each full-length cDNA 
encoding the I-Ac~ and I-AB chains driven by the B-actin promoter 
(26), 10 gg of the plasmid encoding FI-2L  a (La-4), kindly provided 
by Dr. T. Hansen (Washington University, St. Louis, MO), and 
0.5 gg ofpSV2 neo as the selection marker (27). DNA was linear- 
ized before electroporation. Cells were electroporated at room tem- 
perature using a Gene Pulser and Capacitance Extender (Bio-Rad 
Laboratories, Richmond, CA) set at 210 V and 960 #F. Cells sur- 
viving drug selection (0.6 mg/ml G418) were sorted by selection 
for both bA  d and H-2L  d cell surface expression using either Dy- 
nabeads (Dynal Inc., Great Neck, NY) or by FACStar  ~|  (Becton 
Dickinson & Co., Mountain View, CA) and periodically  resorted 
to maintain I-A  a expression. 
T Cell Hybridomas.  The I-Aa-restricted chicken OVA-specific 
T cell hybridomas 3DO 54.8, and DO 11.10 were obtained from 
Dr. P. Marrack (National Jewish Center, Denver, CO) (28); the 
pork insulin-specific hybridoma Pd 2.30 was provided by Dr. P. 
Jensen (Emory University, Atlanta, GA); the hen egg lysozyme- 
specific hybridomas GD3.25.5 and GD5.16 were provided by H. 
Dang and Dr. E. Sercarz (University of California at Los Angeles, 
Los Angeles, CA); the other T cells used in this study, ACh 27.7 
and ACh 8.2, both recognizing horse myoglobin; ACh 48.2 and 
ACh A32, both recognizing alcohol dehydrogenase;  and ACh T40 
which recognizes turkey OVA, were produced in our laboratory 
as follows. BALB/c mice were primed in the rear foot pads with 
50-100 #1 of antigen emulsified in CFA, and 10 d later popliteal 
lymph nodes were harvested and purified T cells were plated at 
5  x  106 in 24-well plates on feeder layers of irradiated syngeneic 
spleen cens plus antigen at 20-50 #g/ml. 4 d later, cells were rephted 
at 5 x  106 in 24-weU plates on feeder layers  of irradiated syngeneic 
spleen cells without antigen. 7-10 d later, T cells were restimu- 
lated and T  cell blasts were fused with BW5147 as previously 
described and cloned in HAT-containing  media (25). The fine spec- 
ificities of these T cell hybridomas have not been determined. 
mAbs.  The hybridomas producing mAbs reactive with I-A  d 
(MKD6, M5/114, K24-199, 25.9.17 SII, 34.5.3S, and Bp107.2.2), 
and with I-A  k (10.2.16), were acquired from American Type Cul- 
ture Collection (ATCC; Kockville,  MD). Their reactivity require- 
ments have been previously  described (29). The anti-I-A  d rat mAb 
B21-2 (30), the anti-FILA-DR  mAb L243 (31), anti-CD8 mAb 2.43 
(32), and the anti-K  k mAb 16.1.11 (33) were also obtained from 
ATCC. Other mAbs reactive against HLA-DR used in these ex- 
periments include HB10.A (34) (obtained from Dr. E. Mellins)  and 
16.23 (24) (obtained  from Dr. R. DeMars, University  of  Wisconsin, 
Madison, WI). 
Antigen Presentation Assays.  APC co-cultures were performed 
as previously described (25). Briefly, 5  x  104  APCs were co- 
cultured with 5 x  104 T cells in 0.2 ml in a 96-well flat-bottomed 
plate with increasing concentrations of antigen. After 16-20 h, 
50 gl of supernatant was removed, frozen, thawed, and then tested 
for lymphokine content by culture with lymphokine-dependent 
cell line CTLb2 as previously  described (35). For assays  involving 
fixation of APCs, cells were harvested and washed 2 x in PBS then 
fixed in 0.1% paraformaldehyde  for 30 rain at room temperature. 
Cells were then washed extensively and added to cultures at the 
doses indicated in the figure legends with 5  x  10  s T cells/well, 
and supernatants were tested for lymphokine content. The T cells' 
dependence on Ii was assessed  by antigen presentation assays  using 
L cells transfected with bA  d with or without genomic Ii, kindly 
provided by Dr. J. Miller (University  of Chicago, Chicago, IL) (36). 
Inhibition of Protein Synthesis and Antigen Presentation.  APCs  were 
pretreated in the presence or absence of 55 #g/ml emetine (Sigma 
Chemical Co., St. Louis, MO) for 4 h before incubation with an- 
tigen, then pulsed with antigen for 6 h in the presence or absence 
of emetine. APCs pulsed with antigen in the absence of emetine 
were treated with 55 #g/ml emetine for I h at the end of the an- 
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tine. All APCs were then washed and fixed as described  above  with 
an additional 2-h culture in complete medium to remove any re- 
sidual emetine. Another set of APCs, used to test the presentation 
of peptide, were treated as above but in the absence of antigen. 
Flow Cytometry Analysis.  MHC cell surface  expression  was mea- 
sured by staining with mAb followed by a secondary staining re- 
agent, FITC-labeled goat  anti-mouse Ig (FITC-GAM) (Cappel 
Laboratories, Cochranville, PA), as described previously (35), and 
analyzed  on a FACScan  |  cytofluorimeter  (Becton  Dickinson & Co.). 
Background fluorescence  was evaluated  using an irrelevant  isotype- 
matched mAb and FITC-GAM or medium alone and FITC-GAM, 
which gave equivalent background staining. 
Western Blot Analysis.  Cells  were lysed at 4  x  107 cells/ml on 
ice in lysis  buffer containing 0.5% CHAPS, 0.5% NP-40, and 50 
#M iodoacetamide  (Sigma Chemical Co.) and the protease inhibi- 
tors PMSF, leupeptin, and TPCK (Boehringer Mannheim Corp., 
Indianapolis, IN).  Nuclei and insoluble debris were removed by 
centrifugation at 16,000 g for 30 min. Postnuclear supernatants 
were adjusted to 0.4% SDS, 10% glycerol, and 0.06 M "Iris, pH 
6.8. In some experiments, the class II molecules  were isolated with 
mAbs/Protein A-Sepharose (PAS) before SDS-gel electrophoresis. 
Immunoprecipitated samples were eluted  in  0.4%  SDS, 10% 
glycerol, and 0.06 M Tris, pH 6.8, at room temperature for 30 
min; one-half was boiled for 5 rain at 1000C while the other half 
remained at room temperature. Proteins were then fractionated by 
SDS-10%-PAGE and were transferred  onto nitrocellulose  membranes 
at 70 V for 6 h. Membranes were blocked overnight in 5% dry 
milk with 0.04% Sigma Antifoam Concentrate and rinsed with 
Tris-buffered saline containing 0.05% Tween 20 (TBST). Class II 
molecules were detected with a 1:10 dilution of the anti-I-A  d mAb 
M5/114 or anti-I-A  k mAb 10.2.16 supernatant or a 1:3,000 dilu- 
tion of the purified anti-DR mAb HB10.A, in a solution containing 
1% dry milk for 4 h then washed extensively  with TBST and then 
incubated with a 1:2,500 dilution of secondary antibody, either 
goat anti-rat horseradish  peroxidase  or GAM horseradish  peroxide 
(GIBCO BRL), in 2.5% milk for 1 h. Membranes were washed 
again as before and developed by chemiluminescence  using ECL 
(Amersham Corp., Arlington  Heights, IL). 
Laser Densitoraetry Measurements.  Density measurements were 
taken on a LKB Laser densitometer. The resulting density curves 
were weighed in order to determine the area beneath each curve. 
Measurements were averaged based on several different exposures 
of each Western blot.  Results are presented as a range of values 
obtained from separate experiments. Ratios of SDS-stable class II 
dimer from the unboiled fraction vs. total class II from the boiled 
fraction were used to control for class II levels  between cells. These 
ratios were used to obtain cell-to-cell comparisons and confirmed 
using the Ambis Optical Imagining System (Ambis, San Diego, 
CA). 
Metabolic Labeling, Imraunoprecipitation, and SDS-PAGE.  Meta- 
bolic labeling and immunoprecipitation  of proteins from transfected 
cells was performed as previously  described (37). Briefly,  cells were 
incubated for 4 h in leucine-free  RPMI 1640 supplemented  with 5% 
dialyzed FCS, then labeled in the same medium containing 0.25 
mCi/ml of [3H]leudne (Amersham Corp.), at 37~  5% COs for 
45 min. Half of the sample was reserved and the remaining cells 
were washed and incubated in medium containing a twofold excess 
of unlabeled leucine for 4 h. Radiolabeled cells were pelleted and 
lysed at  l& cells/ml in a buffer containing  1%  NP-40 (Sigma 
Chemical Co.) and protease inhibitors. Postnudear supernatants 
were precleared with formalin-fixed staphylococcus  A (Immuno- 
Precipitin; GIBCO BILL), adjusted to 5%  dry milk and then 
precleared further by incubation with 4:1 mixture of  PAS/PGS pre- 
bound with irrelevant mAb. Aliquots of the lysate were then in- 
cubated with PAS/PGS prebound with either M5/114, L243, or 
BU45 (The Binding Site, San Diego, CA) and immunoprecipitated 
material was analyzed  by 10% SDS-PAGE. Gels were treated with 
En3Hance (NEN, Boston, MA) and subjected to autoradiography 
at  - 80~ 
Results 
Generation of I.Ad Tran~ctan~ q/'the 8.1.6 and 9.5.3 and 
and T2 APC.  There have been several cell lines identified 
with defects in an MHC-encoded gene(s) that controls class 
II-restricted antigen presentation (15-20).  The 721.174 and 
closely related 174XCEM.T2 (T2) cell line, which was de- 
rived from the 174XCEM.T1  (T1)  fusion, both have large 
homozygous deletions in their MHC regions. Another set 
of parent/mutant human cells (8.1.6 and 9.5.3, respectively) 
have been generated by chemical mutagenesis (17). The mu- 
tations in both the .174 and 9.5.3 cell lines have recently been 
mapped to DM, an MHC-encoded, nonclassical dass II mol- 
ecule (21-23).  Both the T1 and T2 cell lines and the 8.1.6 
and 9.5.3 cell lines were studied in this report, but due to 
the possible contribution of the other class II structural genes 
or other unknown factors missing in the larger T2 deletion, 
we focused the majority of our studies on the 8.1.6 and 9.5.3 
cells. These cells were transfected with genes encoding the 
I-A  d class II and H2-L  d class I molecules. 
Surface Staining of 8.1.6-A'tL 't and 9.5.3-AdL a Cells with Ei- 
ther DR or I-An--specific mAbs.  Although cell surface levels 
of human class II molecules in cells lacking DM expression 
are  unchanged from their respective  parent cell lines,  the 
finding that the mutant cell lines show a marked reduction 
in staining with the DR-specific mAbs 16.23 and 7.3.19 as 
well as the loss of epitopes on DP and DQ suggest that the 
conformation of human dass II molecules is altered (17, 23). 
It was therefore of interest to determine if the routine I-A  d 
molecule would be similarly affected. Fig. 1 is representative 
of several immunofluorescence experiments and shows that 
there were no sdective differences in cell surface staining for 
the I-A  a molecules expressed  on the parent 8.1.6-AdL  a and 
mutant 9.5.3-AaL a transfectants. These results indicate that 
while the lack of DM affects the cell surface conformation 
of several human class II molecules as detected by mAbs, it 
was not possible to detect a conformational change for I-A  d 
with the pand of mAbs tested. 
Murine Class II Matures Normally and Associates with Ii in 
Both 8.I.6 and 9.5.3.  The immunofluorescence  results in Fig. 
1 show that I-A  d expressed  in the parent and mutant dis- 
played  similar reactivity with all mAbs, including the Ii- 
dependent mAb K24-199.  The latter finding suggests that 
a productive interaction takes place between murine class II 
and human Ii molecules.  To confirm that class II/Ii interac- 
tion was normal in these cells and that the species differences 
would not disrupt dass II/Ii interaction, we performed pulse- 
chase immunoprecipitation experiments. Fig.  2 shows the 
results from a kinetic analysis of newly synthesized class II 
molecules with a pulse period of 45 min and a chase period 
of 4 h. The left panel confirms DR/Ii maturation and associ- 
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Figure  1.  FACS  |  analysis of the surface murine class II expression  on 
8.1.6 and 9.5.3 transfected  cell  lines. Cells  were stained  with either MKD6 
(b and  j), M5/114 (c and k), B21.2 (d and/), K24-199  (e and m), Bp107.2.2 
(land n), 34.5.3S (g and o), or 25.9.17 SII (h and p). Staining obtained 
in the absence of primary antibody (a, i) is comparable  to those obtained 
with irrelevant antibody. Panels a-h represent 8.1.6-AdL  d while panels i-p 
represent 9.5.3-AdL  d. Mean channel measurements indicate 9.5.3-AdL  d has 
approximately two- to threefold less I-A  d class II than 8.1.6-AdL  d when 
measured with these various antibodies. 
ation  is  normal  in  the  9.5.3  cell  line,  in  agreement  with 
previous findings (16). More importantly, this analysis revealed 
normal biosynthesis and  transport  of I-A  d c~ and 13 chains 
expressed in human cells. The murine cx/~ dimers assemble 
with human Ii chain, mature coordinately with Ii, and even- 
tually dissociate from Ii in a fashion similar to that observed 
for I-A  a oe/B dimers and routine Ii and for DR and human 
Ii. In addition, these studies indicate that there is no detect- 
able  difference in  the  maturation  patterns  of I-A  d  in  the 
parent  8.1.6  and  mutant  9.5.3  human  cell lines. 
Antigen and Peptide Presentation by the 8.1.6-AaL d and 9.5.3- 
AdL  d Cell Lines  to  T  Cell Hybridomas.  Results  from  the 
DR-restricted antigen presentation studies involving 8.1.6 and 
9.5.3 have shown that DM-deficient cells are defective in the 
presentation of intact antigen to T  cell clones for several an- 
tigens tested, although some uncloned antigen-specific lines 
displayed some reactivity with the mutant  APC  (17).  Fur- 
ther studies also showed that 9.5.3 cells are defective in the 
stimulation of several allo-class II-specific T  cell clones (18). 
To evaluate the relative ability of the mutant and parent APC 
to present antigens using the murine-A  d molecule, we used 
a diverse panel of I-Ad-restricted T  cell hybridomas.  Fig.  3 
shows representative results of antigen presentation experi- 
ments involving the antigens chicken ovalbumin (cOVA), al- 
cohol dehydrogenase (ADH), horse myoglobin (MYO), hen 
egg lysozyme (HEL), and pork insulin (PINS). Fig. 3 k shows 
the presentation of the endogenous antigen H-2L  a to the T 
cell hybridoma BC7. Surprisingly, our experiments indicate 
Figure  2.  Pulse-chase  immunopre- 
cipitation of class II and li from 8.1.6 
and 9.5.3 transfected cell lines. Cells 
were labeled with  [3H]leucine for  a 
45 min pulse (a) and then chased in 
the presence of excess unlabeled leu- 
cine for 4 h (b). 8.1.6-AdL  d (lanes 1, 
3, 5) or 9.5.3-AaL  a (lanes  2, 4, 6) were 
lysed and  immunoprecipitated with 
the anti-DR mAb L243 (lanes la-2b), 
anti-I-AdB mAb M5/114 (lanes 3a-4b), 
or anti-Ii mAb BU45 (lanes 5a-6b). 
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ence in the ability of the 9.5.3 cell line to present exogenous 
or endogenous  antigen  relative to the 8.1.6 cell line. 
These data suggest that I-Ad-restricted antigen presenta- 
tion may not be dependent on functional DM expression for 
the panel of T  cells  tested.  To verify that  the presentation 
seen was due to processing of internalized  antigen and not 
due to contaminating  peptides in our antigen  preparation, 
we tested our cells' ability to present  intact  antigen  when 
fixed.  Fig. 4 shows representative results of the antigen pre- 
sentation experiments done for all T  cells with fixed APC. 
These  results  show  that  presentation  of intact  antigen  is 
blocked by fixation, whereas presentation of exogenous pep- 
tide is not.  This suggests that  the stimulation  of antigen- 
specific T cells by both cell lines is not due to contamination 
of our antigens by peptides but to the processing and presen- 
tation of intact antigen through a fixation-sensitive pathway. 
To explain the absence of any DM requirement  in bA  d- 
restricted  antigen presentation, we considered that DM might 
not  interact  productively  with  the  I-A a  molecule.  This 
would  render  both  cells  effectively  mutants,  since  I-A  d 
would essentially function without DM in both cells. This 
hypothesis predicts that the actual efficiency of antigen pre- 
sentation in both cells would be quite low. To test this hy- 
pothesis, we compared the antigen presentation ability of the 
8.1.6 transfectants with the murine B cell lymphoma A20. 
Fig. 5 shows that even across the species barrier,  8.1.6-AaL a 
is quite competent at antigen presentation.  Presentation of 
peptide by the 8.1.6 transfectant was equal to or better than 
A20 for all T cells tested across a peptide dose-response curve 
(data not shown). These results argue against the possibility 
that the equivalent I-Aa-restricted antigen presentation seen 
for 9.5.3 and 8.1.6 reflects the presence of a defect in both 
cells.  Rather,  our results support the notion that  the func- 
tional competence of I-A  d may be independent  of DM. 
Equivalent  Antigen Presentation Between Parent and Mutant 
Is Observed  for Both Ii-dependent and Ii-independent Epitopes and 
Is Sensitive to Protein Synthesis Inhibitors.  One possible way 
in which class  II antigen  presentation  may proceed in the 
absence of DM is through the use of recycled class II mole- 
cules. In fact, a recent study has shown that an epitope from 
a viral protein can be presented by recycled class II molecules 
in DM-deficient cell lines (38). To address this issue, we ini- 
tially examined our panel of T  cell hybridomas for depen- 
dence on Ii. Since Ii enhancement  presumably occurs with 
newly synthesized class  II molecules, we reasoned that  Ii- 
dependent T  cells would not be able to effectively use recy- 
cled class II molecules. We therefore tested our T  cell panel 
for dependence on or enhancement by Ii, using L cells trans- 
fected  with  class  II  I-A d with  or  without  expression  of 
genomic Ii.  The results of these studies, shown in Table  1, 
indicated that our T cell panel contained several T ceils that 
show enhanced  antigen  presentation  in  the presence of Ii. 
Thus, in our system, Ii dependence is not an accurate predictor 
of dependence on DM. 
We then  considered that  despite the ability of Ii to en- 
hance I-Aa-restricted antigen presentation  to some T  cells, 
it was possible that 8.1.6 and 9.5.3 are particularly capable 
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Table  1.  Ii Dependence for Antigen-specific T  Cell Hybridomas 
T  cell  Antigen  Effect of Ii 
ACh A32  ADH  None 
ACh 48.2  ADH  + + + 
3DO 54.8  cOVA  None 
DO 11.10  cOVA  None 
GD3.25.5  HEL  + 
GD5.16  HEL  + 
ACh 8.2  hMYO  None 
ACh 27.7  hMYO  + 
Pd 2.30  PINS  + 
ACh T40  tOVA  None 
This table represents data showing either no effect  of li (None), <5-fold 
enhancement (+), or a >20-fold enhancement (+ + + ). Antigens are: 
cOVA, tOVA, ADH, HEL, hMYO, and PINS. 
of using class  II molecules from recycled sources and that 
this might account for our failure to observe an antigen pre- 
sentation defect in 9.5.3.  To test this possibility, we exam- 
ined several of the T  cells' requirements  for newly synthe- 
sized class  II  molecules in  antigen  presentation  using  the 
transfected human lymphoblastoid cells.  One of these was 
Ii independent  (3DO 54.8) and two T  cells that  showed a 
slight Ii enhancement (GD3.25.5 and GD5.16). In the study 
by Pinet et al. (38), DM-independent presentation via recy- 
cled class II was not blocked by treatment  with  a protein 
synthesis inhibitor.  We therefore tested the ability of both 
the 8.1.6 and 9.5.3 to present antigen to T  ceils after treat- 
ment with emetine.  Fig. 6 shows that emetine treatment effec- 
tively inhibited antigen presentation to the T cells tested, while 
it  did not  inhibit  peptide presentation.  Collectively, these 
results suggest that  antigen presentation  in our system re- 
quires newly synthesized class II molecules or some other 
protein with a relatively short half-life. Together, our experi- 
ments suggest that  the DM-independent  antigen presenta- 
tion seen in the 9.5.3 cell line is not due to a known alterna- 
tive mechanism  of antigen  presentation. 
DR and I-A d SDS-stable  Dimer Formation in the 8.1.6-AdL d 
and 9.5.3-AdL d Cell Lines.  To further examine the function 
of I-A  d in the parent and mutant cells, we employed an ad- 
ditional assay that is thought to reflect peptide binding:  an 
assay that shows the ability ofdass II molecules to form SDS- 
stable dimers (8-12). The ability of I-A  d to form SDS-stable 
dimers in the 8.1.6 and 9.5.3 cell lines as well as in the T1, 
T2,  and the murine B cell A20 was analyzed.  In these ex- 
periments we also sought  to confirm  the observation that 
the  mutant  9.5.3  and  our  9.5.3-AdL  d transfectants  were 
deficient in  the production  of DR SDS-stable dimers.  As 
shown  in  Fig.  7  A,  9.5.3  and  9.5.3-AaL  d both  show  a 
marked decrease in the production of DR SDS-stable dimer 
relative to the parent cell line 8.1.6.  Laser densitometry mea- 
surements, performed in several different experiments of this A 
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Figure  3.  Antigen presentation by 8.1.6 
and 9.5.3 transfected cell lines to l-Ad-re - 
stricted T cell hybridomas. 5  x  10  s APCs, 
either 8.1.6-AdL  d (solid circles) or 9.5.3-AdL  d 
(open circles) were cultured  with 5  x  10  s 
T cell hybridomas.  (A) Panels (a-j)  repre- 
sent presentation  of exogenous  native an- 
tigen present at the time of APC/T call 
co-culture. Panel (k) represents the presen- 
tation of the endogenously  synthesized L  d 
epitope  to BC7. (B) Peptide presentation 
by unfixed APC to a representative sample 
ofT cells from (A). Peptides were prepared 
by trypsin digestion of each antigen.  Ab- 
breviations:  cOVA,  chicken  ovalbumin; 
tOVA, turkey ovalbumin; MYO, horse myo- 
globin; PINS, pork insulin; HEL, hen egg 
lysozyme;  ADH, alcohol  dehydrogenase. 
During the course of the antigen presenta- 
tion studies, parent and mutant cells either 
had the two- to threefold differences in cell 
surface density  of I-A  d (mutant two-  to 
threefold lower than parent) shown in Fig. 
1 or were indistinguishable in I-A  d cell sur- 
face density,  with the same results. 
type quantified this as 15-30-fold reduction. Examination of 
the  I-A  a  SDS-stable  dimer  in  these  cells  led  to  two 
significant observations.  First,  in contrast to the results ob- 
tained  with  DR,  I-A  a SDS-stable  dimer  formation  is  de- 
creased  in the mutant cell line only by a factor of 2 to 4 as 
measured by densitometry,  a result we have reproduced in 
numerous experiments (Fig. 7, B and C). These experiments 
suggest  that while DM  does affect  I-A  a SDS-stable dimer 
formation, it does so less severely than it does DR. Our second 
observation  was  that  I-A d produces  much less  SDS-stable 
dimer in 8.1.6  than does DR,  relative to total or unstable 
class  II molecules. 
Comparison of SDS-stable Dimer Formation in Different Cel- 
lular Contexts.  To examine whether  the overall  deficiency 
in the generation  of I-A  a SDS-stable dimer was due to an 
inherent property of I-A  d or to a result of the species mixing 
of proteins from the human APCs and the murine class  II 
molecules, we extended our studies to several additional cell 
types,  using an immuno-Western procedure in which class 
II molecules  are first  isolated by immunoprecipitation  and 
then prepared for a normal Western blot. Fig. 8 shows that 
although T1-A a produces SDS-stable dimer at levels com- 
parable  to the murine B  cell line A20,  both the 8.1.6  and 
9.5.3 cell lines produce far less, a 20-fold reduction in 8.1.6 
and an 80-fold reduction in 9.5.3  as compared with  A20. 
In these experiments we also assessed whether allelic poly- 
morphism might affect the formation of SDS-stable dimers. 
Fig. 8 shows that the mutant T2 cell line does not produce 
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significant levels  of I-A  a SDS-stable dimer. In contrast, I-A  k 
molecules  maintain high levels of SDS-stable dimer in the 
T2 cell line (Fig.  9).  Although the total amount of I-A  k is 
somewhat lower in the T2 transfectant  when compared with 
the T1 transfectant, the amount of SDS-stable dimer relative 
to the total number of class II molecules is equal. The den- 
sitometry measurements revealed ratios of SDS-stable dimer 
to total class II in T1/T2  that ranged between  1:0.96 and 
1:1.51  for I-A k,  in contrast  to the phenotype observed for 
I-A  a, where  SDS-stable dimer in the mutant was <2%  of 
40000 t Antigen 
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I 
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Figure  4.  Effects of fixation on the ability of 8.1.6 and 9.5.3 transfected 
cell lines to present antigen and peptide. 5  x  10  s APC, either fixed with 
0.1% paraformaldehyde or unfixed, were cultured with 5  x  10  s T cell 
hybridomas and antigen or peptide at a concentration of 1 rag/m1 except 
for intact OVA which was at  10 mg/ml. 8.1.6-AaL  d (solid, unfixed; stip- 
pled,  fixed)  and 9.5.3-AdL  a (striped, unfixed; open, fixed) presentation  of 
antigen  or peptide  to  three  representative  T  ceils from normal antigen 
presentation  experiments. 
that  observed in  the  parent.  These  findings  suggest  that 
different allelic forms of class II molecules are distinctive in 
their requirements for SDS-stable dimer formation and rein- 
force the hypothesis that DM gene products may not play 
a requisite role in many of the biological activities of the class 
II molecule. 
Discussion 
Previous studies have shown that the mutant cell line 9.5.3 
has lost some conformational epitopes normally expressed on 
cell surface DR, lacks antigen presentation by DR,  and the 
ability of DR. and DP dimers to remain stable in SDS (16, 
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Figure 5.  Comparison of antigen 
presentation ability of A20 and 8.1.6. 
5  x  105 APCs, either A20 (open 
squares)  or 8.1.6-AdL d (solid circles), 
were cultured with 5  x  10  s T cell 
hybridomas. Indicated in each panel 
is the T  cell used  and its  antigen 
specificity.  Culture  supernatants 
were tested for lymphokine content 
using the CTLL cell line as described 
in  Materials  and  Methods.  Data 
shown represent  average cpm from 
triplicate cultures. 8.1.6-Ad 
100OO0  8OOOO, 
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Figure 6.  Effects  of emetine on the ability of 8.1.6 and 9.5.3 trans- 
fected cell lines to present antigen and peptide. APCs were treated with 
55 #g/m1 emetine for 4 h or cultured in medium alone. APCs were then 
pulsed with antigen for an additional 4 h in the presence or absence of 
emetine. APCs pulsed with antigen  in the absence ofemetine were treated 
with 55/~g/ml emetine for 1 h at the end of the antigen pulse. Cells used 
for peptide control  were treated in parallel without antigen. 5  x  105 
APCs either treated (solid bar) or untreated (open bar) were cultured with 
5  x  105 T cells. For GD3.25.5 and GD5.16, APCs were pulsed with 10 
mg/ml HEL; for 3DO 54.8, APC were pulsed with 10 mg/ml cOVA. 
The peptide used for 3DO 54.8 was a tryptic digest of cOVA at 1 mg/ml. 
No enhancement of peptide presentation was seen for emetine-treated APC 
with several other T  cells tested. 
Figure 8.  Comparison of SDS-stable dimer levels  between 8.1.6-AdL  d, 
9.5.3-AdL  d, T1-AdL  d, T2-AaL  d, and A20. Cell were lysed in 0.5% CHAPS 
as for an immunoprecipitation  experiment, as described in Materials and 
Methods.  Class II molecules were isolated from the lysates using PAS- 
bound  MKD6. Class II molecules were eluted from the PAS by incubation 
in sample buffer containing 1.0%  SDS. Eluted samples were then split 
and half were subjected to boiling (/t panels) or loaded directly (B panels). 
Lanes are A20 (IA-IB),  8.1.6-AaL  d (2A-2B),  9.5.3-AdLd (3A-3B),  T1- 
AaL  d (4A-4B), and T2-AdL  d (5A-5B). Laser densitometry measurements 
indicate that,  when normalized to total class II molecules in the boiled 
sample, T1-AaL  a produces 50% the stable dimer of A20, 5% 8.1.6-AdL  d, 
and 1.25% 9.5.3-AaL  a. T2-AdL  d produces no detectable SDS-stable class 
II dimers. 
17). Recent studies have shown that 9.5.3 has a point muta- 
tion in the DMB gene (22). To examine whether the pheno- 
types observed in these cell lines reflect a generalizable phe- 
nomenon, we undertook a series of studies to determine the 
biological impact of this mutation on I-A  a.  To  accomplish 
this,  we  transfected  the parent  and mutant cell lines with 
Figure  7.  Analysis of class II 
dimer  stability  in the parent  cell 
line 8.1.6 and mutant 9.5.3.  Cell 
lines 8.1.6 and 9.5.3 were lysed  in 
CHAPS/NP-40 lysis buffer. Post- 
nuclear supernatants were then ad- 
justed to 1% SDS and incubated for 
30 rain at room temperature.  Samples 
were split in half and either boiled 
for 5 min (lanes A) and separated 
by SDS/PAGE or loaded directly 
without boiling (lanes B). Proteins 
were transferred onto nitrocellulose 
membranes, probed with the anti- 
DR  mAb HB10.A  (panel A)  or 
anti-I-Ad3 mAb M5/114 (panels B 
and  C),  and developed by ECL. 
SDS-stable dimer is marked by the 
bracket and unstable class II by an arrow. (.4) Western probed with HB10.A to determine DR stability of 8.1.6 (lanes 1A-IB),  9.5.3 (lanes  2A-2B), 
8.1.6-AaL  d (lanes 3A-3n),  and 9.5.3-AdLd (lanes 4A-4B). Laser densitometry  of autoradiograms indicated that 8.1.6 produces 15-30-fold greater levels 
of SDS-stable DR dimer than 9.5.3.  (B) Western blot probed with anti-I-Ad3 mAb M5/114 to determine I-Aa stability on 8.1.6-AdL  d (lanes la-l~), 
and 9.5.3-AdL  a (lanes 2A-2~). Densitometry measurements indicate that  the level of SDS-stable bAd in 8.1.6 is only two- to fourfold greater than 
that of 9.5.3.  (C) Long exposure of panel B. 
230  MHC-linked Genes in Class II-restricted  Antigen Presentation Figure  9.  Western blot analysis of SDS-stable dimer formation in T1- 
A k and T2-A  k.  Cells were lysed for a normal Western blot,  transferred 
to  nitrocellulose,  and  probed  with  the  anti-l-A  k mAb  10.2.16.  Lanes 
IA-1B and 3A-3B represent T1-A  k and lanes 2/t-213 and 4A-4B are T2- 
A k. These cells are not matched for class II I-A  k surface expression. Mean 
channd measurements from FACS  |  analysis indicate that T1-A  k has two- 
fold more I-A  k at the cell surface than T2-AL 
the genes encoding I-A  a and examined a number of pheno- 
typic characteristics that correlate with antigen presentation. 
To determine if a change in class  II conformation could 
be detected for I-A  a,  we used an  extensive panel of bA  d- 
specific  mAbs.  These  analyses  indicated  that  the mutation 
in DM has no discernible effect on I-A  d mAb epitopes, in- 
cluding one mAb epitope that is enhanced by Ii association 
with class II, K24-199.  Although  the use of a broad panel 
of mAbs that  react with distinct  class  II epitopes suggests 
that  bA  d conformation  is not affected by the lack of func- 
tional DM, it is possible that there are segments of the I-A  d 
molecule that  are altered by the mutation  in  9.5.3 but are 
not detected by the mAbs tested. The experiments described 
here  also  evaluated  I-Ad-restricted  antigen  presentation  in 
the mutant cell lines. Our results,  which were compiled using 
11 different T  cells and 7 different antigens,  led to the con- 
clusion that  I-Aa-restricted  antigen  presentation  is not de- 
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tectably dependent on DM. Parent and mutant cell lines trans- 
fected with the routine class II molecule I-A  d were able to 
process and present exogenously added antigen with similar 
efficiency. In addition, parent and mutant transfectants were 
equally effective at presenting an endogenous antigen,  H2- 
L d.  We have also shown that  the ability to present antigen 
in the absence of DM holds for both Ii-dependent and Ii-inde- 
pendent  T  cells.  Additionally,  our  studies  revealed  only a 
modest impact of the 9.5.3 defect on the ability of I-A  a to 
form SDS-resistant dimers,  significantly less than  those de- 
tected for DR.  It is interesting  that  the  absolute levels  of 
I-A  a SDS-stable dimer  appear to be quite low in the 8.1.6 
cell. This could not be attributed to a generalizable property 
of I-A  d because I-A  d forms  relatively  high  levels  of SDS- 
stable dimers in the B cell line A20, nor to some consequence 
of a species mismatch of the murine class II structural proteins 
within  a heterologous cellular  context because I-A  d forms 
SDS-stable dimers in T1 and loses this property in T2. Matu- 
ration of both human DR and murine I-A  a appears normal 
in both parent  and mutant  cell lines,  as do association and 
dissociation with Ii. Finally,  we evaluated whether different 
allelic forms of class II molecules have similar requirements 
for SDS-stable dimer formation.  Based on our observation 
that I-A  k is capable of maintaining  stable dimers in T2 while 
I-A  d is not,  it appears  that DM is differentially required for 
expression of SDS-stable dimers by different class II molecules. 
Collectively,  our results suggest that the requirement for DM 
may differ for structural  variants  of the class  II molecule. 
I-ACrestricted Antigen Presentation by 8.1.6 and 9.5.3 Trans- 
fectants.  Our first finding, that there was no apparent differ- 
ence in antigen presentation between 8.1.6 and 9.5.3,  is of 
importance because it suggests that the function controlled 
by DM may not be ubiquitously required for presentation 
of all antigens  and/or  for all MHC class II molecules.  We 
have considered a number of possible mechanisms to explain 
why DM is apparently not required for I-Ad-restricted an- 
tigen presentation.  Two observations suggest that  it is un- 
likely that our results reflect a failure of murine class II mole- 
cules  to  interact  productively  with  human  DM-encoded 
proteins (thereby effectively making both 8.1.6 and 9.5.3 mu- 
tants for I-Aa).  First,  8.1.6 and the routine B cell line A20 
present antigen equivalently for most T ceUs  tested, and second, 
I-A  d forms SDS-stable dimers in T1 at levels comparable to 
A20 and  forms none in  T2. 
If in this system, I-A  a does not require DM,  how might 
it  achieve  this  independence?  One  possibility  is  that  the 
I-Aa-restricted antigen presentation pathway has options for 
antigen  presentation  that  do not rely on DM.  This could 
be an alternative pathway of antigen presentation  that I-A  a 
can or does use that does not depend on DM. For example, 
DM may regulate access of dass II molecules to an intracel- 
lular  compartment  that  is requisite for DR-restricted  pre- 
sentation  but  not  used extensively by bA  d  .  Alternatively, 
I-A  d might have a structure that either by itself or through 
association with human Ii, mimics some conformation that 
is normally  imparted by interaction  with DM.  Either  sce- 
nario suggests a role for DM that is not critical for all class 
II-restricted antigen presentation. This type of activity would thus be in contrast to the generalized need for TAP proteins 
in class  I-restricted presentation. 
A second possible explanation for the dichotomy between 
I-A  a- and DR-restricted antigen presentation is that the an- 
tigens used for the I-A  d and DR studies might be distinc- 
tive in some generalizable way. One difference in the two 
systems is the nature of the antigens and/or mode of immu- 
nization used to elicit the T cells. Typically in human studies, 
antigens are limited to those naturally encountered by an in- 
dividual. Three of the antigens tested for presentation in the 
context of DR, gp 350, HBsAg, and purified protein deriva- 
tive (PPD), are derived from pathogens that naturally access 
endogenous presentation routes, while the fourth,  tetanus 
toxoid, is a bacterial product (17). In contrast, the T cells used 
in our I-Aa-restricted model system were generated in re- 
sponse to soluble antigens in adjuvant introduced subcutane- 
ously. Due to the differences in the primary stimulation in- 
volved in these responses, epitope generation might rely on 
different internal proteins. If this is true, we would then ex- 
pect that I-Aa-restricted presentation of pathogenic antigens 
to T cells generated in mice by normal parasitic infection might 
be more dependent on DM,  a possibility we are currently 
investigating. Thus, it is possible that although we have used 
a broad panel of T cells and antigens, our panel nonetheless 
excludes epitopes that  are DM dependent. The possibility 
that there is microheterogeneity in DM dependence even for 
a given class II restriction element has recently been suggested 
by Pinet et al. (38). Finally, it is possible that DM does par- 
ticipate in I-Ad-restricted antigen presentation but its effect 
can only be detected under limiting conditions other than 
cell number and antigen concentrations, those tested in our 
system. 
EffTciency of  Antigen Presentation  Does Not Correlate with SDS- 
stable Dimer Formation.  Our second key observation is that 
across several different cell lines, there appears to be little corre- 
lation between antigen presentation ability and the extent 
of SDS-stable dimer formation. Our data have shown that 
SDS-stable dimer formation is reduced 4-fold between 8.1.6 
and 9.5.3  and 20-fold between A20 and 8.1.6.  Neither of 
these reductions had any observable effect on antigen presen- 
tation by the I-A  d class  II molecule expressed within these 
cells.  We can hypothesize two separate explanations to ac- 
count for this observed dichotomy. First, SDS-stable dimer 
formation for I-A  a may be conferred primarily by a minor 
set of peptides that vary from cell to cell. This possibility 
is supported by the finding that the majority of peptides iso- 
lated from purified dass II molecules belong to a small number 
of proteins that are primarily derived from within the APC 
and that vary depending on the particular allele of class II 
studied (39-41). Second, dissociation ofSDS-stable dimer for- 
mation and antigen presentation could result if SDS-stable 
dimers are generated from the general pool ofpeptides within 
the cell but require precisely trimmed peptides. For example, 
longer peptides, although still capable of activating T cells, 
might not readily confer the SDS-stable phenotype. That only 
a subset of MHC binding peptides confer SDS-stable dimer 
is supported by recent in vitro binding studies as well as by 
studies with live APC (11, 42, 43). Certainly, the CLIP pep- 
232  MHC-linked Genes in Class 
tide(s) belong to the category of peptides that can bind to 
class II molecules yet fail to confer the SDS-stable phenotype 
(20,  44). 
The Function of  DM in MHC Class II-restricted Antigen Pre- 
sentation.  Upon the initial description of these mutants, a 
number of protein functions could be imagined that would 
lead to impaired SDS-stable dimer formation and antigen pre- 
sentation. Among these might be proteins that mediate cru- 
cial class II trafficking events or loading of peptides onto the 
class II molecule. Any model that describes the function of 
DM in the mutants must now .accommodate the following 
results. First, the ability of at least one MHC dass II restric- 
tion element (I-A a) to present a variety of antigens is inde- 
pendent of DM. Second, in the T1/T2 cell lines using SDS- 
stable dimer as an assay for peptide binding to class II mole- 
cules, different alleles of murine class II are differentially de- 
pendent on DM.  Third, T1 and 8.1.6 differ in their ability 
to  form  I-A  a SDS-stable  dimer.  Finally,  recent  studies by 
other groups have shown that loss of DM results in an en- 
richment of an Ii fragment (CLIP) on the class II molecule 
(20,  44). 
Most of these observations can be reconciled with a model 
in which DM keeps the MHC class II binding pocket flee 
of CLIP. DM may function by extracting CLIP from the 
groove, removing CLIP from the peptide pool, or by medi- 
ating some transport event that leads to the separation of CLiP 
from the class II molecule. By any of these activities the ab- 
sence of DM would lead to CLIP persistence on the class 
II molecule. This phenotype might be allele dependent based 
on the affinity of the CLIP peptide for the class II allele under 
examination. In this regard it is interesting to note that whereas 
I-A  d and DR have similarly high affinities for human CLIP, 
I-A  k is estimated to have as much as 1,000-fold lower affinity 
(Sette,  A.,  personal communication).  Consequently,  I-A  k 
may not need DM to have its binding pocket available  for 
peptides that can confer SDS-stable dimers, which is consis- 
tent with its ability to form SDS-stable dimers in T2. Addi- 
tionaUy, a variable impact of DM on antigen presentation 
can be explained if the persistence of CLIP on the class II 
molecule only affects presentation of those epitopes where 
the availability of"empty" class II per se is the limiting factor 
in antigen presentation. Thus, this model predicts that for 
I-Aa-restricted antigen presentation, empty I-A  a may not be 
the limiting element for epitope generation. 
One prediction of this model is that the lack of DM would 
negatively affect SDS-stable dimer formation and antigen pre- 
sentation only in the presence of Ii. In several models, class 
II and Ii molecules are introduced into cells that lack consti- 
tutive expression of class II, Ii, and possibly other coregu- 
lated molecules such as DM. Antigen presentation is frequently 
imparted by the expression of the class  II molecules alone 
and can be significantly augmented by transfection with Ii 
(36, 45-48). If these cells lack expression of DM, one would 
anticipate that Ii expression would actually antagonize an- 
tigen presentation by effectively removing a significant amount 
of available  class II molecules. This might certainly be ex- 
pected in the case of a class II molecule that has a high affinity 
for CLIP, such as I-A  d or DR. However antagonism of an- 
lI-restricted Antigen Presentation tigen presentation by Ii has not been observed  thus far (36, 
45). One possible way to reconcile these results is the ability 
of Ii to enhance the export of class II molecules from the 
ER to endocytic compartments might balance the loss of avail- 
able class II molecules later in the endosomal compartments 
due to CLIP binding (49,  50). 
Regardless of the specific role or function of DM, these 
results show three dear observations. First, the antigen presen- 
tation defect seen for DR in the 9.5.3 cells does not detect- 
ably impair antigen presentation by I-A  d. Second,  changes 
in the level of SDS-stable  dimer formation are not directly 
related to changes in antigen presentation. Finally, different 
class II alleles have unique requirements for SDS-stable dimer 
formation and different cell types may vary in their ability 
to meet these requirements. These results question our cur- 
rent understanding of SDS-stable dimer formation and em- 
phasize  the need for greater understanding of the elements 
that are limiting and required for class II-restricted antigen 
presentation as a whole. Elucidation of these issues will be 
necessary to further unravel the mechanisms of class II-re- 
stricted antigen presentation. 
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